Year: 2017
Type: article
Abstract: Loss of synapses and neurons is the primary feature of neurodegenerative pathology. The development of novel, disease-modifying medication requires the ability to identify patients in early (even presymptomatic) stages of disease and follow the progress of the neurodegenerative process within
Source: Journal of Nuclear Medicine
Author: Eugenii A. Rabiner
Institution: King's College London
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2767748226
